Fungal Otitis Externa As A Cause of Tympanic Membrane Perforation: A Case Series
Fungal Otitis Externa As A Cause of Tympanic Membrane Perforation: A Case Series
Fungal Otitis Externa As A Cause of Tympanic Membrane Perforation: A Case Series
com)
Fungal otitis externa as a cause of
tympanic membrane perforation: A
case series
August 27, 2014 by James Eingun Song, MD; Thomas J. Haberkamp, MD; Riddhi
Patel, MD;
Miriam I. Redleaf, MD
Abstract
We describe a series of 11 patients-8 men and 3 women, aged 18 to
70 years (mean: 46.0)-who had fungal otitis externa that had been
complicated by a tympanic membrane perforation. These patients
had been referred to us for evaluation of chronic, mostly treatmentrefractory otitis externa, which had manifested as otorrhea, otalgia,
and/or pruritus. Seven of the 11 patients had no history of ear
problems prior to their current condition. Five patients had been
referred to us by a primary care physician and 4 by an
otolaryngologist; the other 2 patients were self-referred. All patients
were treated with a thorough debridement of the ear and one of two
antifungal medication regimens. Eight of the 11 patients
experienced a complete resolution of signs and symptoms, including
closure of the tympanic membrane perforation. The other 3 patients
underwent either a tympanoplasty (n = 2) or a fat-graft
myringotomy (n = 1) because the perforation did not close within a
reasonable amount of time. This series demonstrates that the
nonspecific signs and symptoms of fungal otitis externa can make
diagnosis difficult for both primary care physicians and general
otolaryngologists. This study also demonstrates that most cases of
tympanic membrane perforation secondary to fungal otitis externa
will resolve with cleaning of the ear and proper medical treatment.
Therefore, most patients with this condition will not require surgery.
Introduction
Results
Five patients had been referred to us by a primary care physician and 4 by
an otolaryngologist; the other 2 patients were self-referred. At
presentation, all patients had chronic otitis externa of 2 weeks' to 12
months' duration (table). Their condition was marked by otorrhea, otalgia,
and/or pruritus. All 9 patients who had been referred by a physician had
been treated with some form of antibiotic treatment prior to referral.
EAC
drain
age
Outcome
Closure of
the TM
perforation
Refe
rral
sour
ce
18/M
PCP
OE
(9
mo)
Yes
Yes
Yes
1.5
mo*
32/F
PCP
OE
(2.5
mo)
Yes
Yes
Yes
9
mo*
Closure of
the TM
perforation
38/M
PCP
OE
(1.5
mo)
No
Yes
No
3 mo
Closure of
the TM
perforation
41/M
ENT
OE
(1
mo)
Yes
Yes
Yes
8 mo
Closure of
the TM
perforation
ENT
OE
(3
mo)
3 mo
Tympanopl
asty and
ossiculopla
sty
47/M
Self
OE
(2
wk)
Yes
Yes
No
1 mo
Closure of
the TM
perforation
50/M
ENT
OE
(12
mo)
No
Yes
Yes
4 mo
Closure of
the TM
perforation
50/M
Self
OE
(2
mo)
No
Yes
Yes
3 mo
Closure of
the TM
perforation
55/M
ENT
OE
(1
mo)
No
Yes
Yes
3
mo*
Fat-graft
myringopla
sty
PCP
OE
(1
mo)
2 mo
Closure of
the TM
perforation
Age/sex
47/F
58/M
No
No
EAC
and
TM
ede
ma
Type
and
dura
tion
of
ther
apy
Reas
on
for
refer
ral
Yes
Yes
Yes
Yes
70/F
PCP
OE
(6
mo)
No
Yes
Yes
7.5
mo*
Tympanopl
asty
Discussion
Fungal otitis externa can be a difficult diagnosis for primary care
physicians and even general otolaryngologists, since its signs and
symptoms often mimic those of bacterial otitis externa and otitis media.
Unfortunately, an incorrect diagnosis can lead to a prolonged course and
to complications such as tympanic membrane perforations.
References
1
2
3
4
5
6
7
8
9
Pontes ZB, Silva AD, Lima Ede O ,et al. Otomycosis: A retrospective study.
Braz J Otorhinolaryngol 2009; 75 (3): 367-70.
Hawke M, Wong J, Krajden S. Clinical and microbiological features of otitis
externa. J Otolaryngol 1984; 13 (5): 289-95.
Kurnatowski P, Filipiak A. Otomycosis: Prevalence, clinical symptoms,
therapeutic procedure. Mycoses 2001; 44 (11-12): 472-9.
Dyckhoff G, Hoppe-Tichy T, Kappe R, Dietz A. Antimycotic therapy in
otomycosis with tympanic membrane perforation [in German]. HNO 2000;
48 (1): 18-21.
Ho T, Vrabec JT, Yoo D, Coker NJ. Otomycosis: Clinical features and
treatment implications. Otolaryngol Head Neck Surg 2006; 135 (5): 78791.
Munguia R, Daniel SJ. Ototopicalantifungals and otomycosis: A review. Int J
PediatrOtorhinolaryngol 2008; 72 (4): 453-9.
Hurst WB. Outcome of 22 cases of perforated tympanic membrane caused
by otomycosis. J LaryngolOtol 2001; 115 (11): 879-80.
Oztrkcan S, Dndar R, Katilmis H ,et al. The ototoxic effect of boric acid
solutions applied into the middle ear of guinea pigs. Eur Arch
Otorhinolaryngol 2009; 266 (5): 663-7.
Lundy LB, Graham MD. Ototoxicity and ototopical medications: A survey of
otolaryngologists. Am J Otol 1993; 14 (2): 141-6.
From the Department of Dermatology, University of California, Irvine (Dr.
Song); the Department of Otolaryngology, Cleveland Clinic (Dr.
Haberkamp); the Department of Surgery, University of Chicago Medicine
(Dr. Patel); and the Illinois Eye and Ear Infirmary, Chicago (Dr. Redleaf).
The study described in this article was conducted at the Illinois Eye and
Ear Infirmary.
Corresponding author: James Eingun Song, MD, Department of
Dermatology, University of California, Irvine, 118 Med Surge I, Irvine, CA
92697. Email: [email protected]
Ear Nose Throat J. 2014 August;93(8):332-336